Establishing clinical severity for PROMIS® measures in adult patients with rheumatic diseases V Nagaraja, C Mara, PP Khanna, R Namas, A Young, DA Fox, T Laing, ... Quality of Life Research 27 (3), 755-764, 2018 | 56 | 2018 |
Successful treatment of central nervous system vasculitis associated with relapsing polychondritis with cyclophosphamide M Almackenzie, A Alharbi, S Alhassan, E Cook, N Altorok The American Journal of the Medical Sciences 353 (5), 495-497, 2017 | 7 | 2017 |
Renal injury in scleromyxoedema due to monoclonal gammopathy associated C3 glomerulonephritis S Kao, SDS Krupnikova, M AlMackenzie, G Atefi BMJ Case Reports CP 15 (11), e250296, 2022 | | 2022 |
Anti HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies; A Case Series M Almackenzie, lisa Rider, R Curiel 4th Global Conference on Myositis, 2022 | | 2022 |
COVID catalyst: telemedicine in rheumatology protects patient care beyond just the pandemic A Kilian, M Chand, M Almackenzie, N Mbuy, S Bilal, G Atef, ... International Journal of Clinical Rheumatology, 2021 | | 2021 |
Establishing Clinical Severity for Patient Reported Outcomes Measurement Information System Measures in Adult Patients with Rheumatic Diseases V Nagaraja, C Mara, CV Dodge, D Fox, P Khanna, T Laing, WJ McCune, ... ARTHRITIS & RHEUMATOLOGY 68, 2016 | | 2016 |